Evaluation of a combination of herbs against raised blood sugar

Phytochemical and biologial evaluation of polyherbal extract against Type 2 Diabetes Mellitus

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043069

Enrollment

120

Registered

2022-06-07

Start date

Unknown

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Willing to give consent to participate in the study. 2. Sex-Both male and female in between 30 years and 60 years age group. 3. Patients having classical symptoms of diabetes and unequivocal blood sugar elevation. 4. Fasting blood sugar >= 126 mg/dl and up to 250 mg/dl. 5. Postprandial blood >= 200 mg/dl and up to 350 mg/dl. 6. Patients with uncontrolled of blood sugar in spite adequate doses of OHDs. 7. Patients having complication of diabetic neuropathy. 8. Uncontrolled cases of Type-2 DM, those on Conventional treatment (not more than one year).

Exclusion criteria

Exclusion criteria: 1. Patients in > 30 years and 2. Patients of IDDM or juvenile onset diabetes. 3. Patients of Type-2DM with severe grade blood glucose levels (fasting >200 mg/dl and PP > 350 mg/dl) 4. Patients of severe Diabetic complications such as cardiopathy, nephropathy, foot Gangrene etc and other endocrine disorders. 5. Pregnant and Lactating Mothers. 6. History of recurrent infections. 7. Patients on corticosteroid therapy. 8. Uncontrolled cases of Type-2 DM, those on Conventional treatment (more than one year). 9. Patient not willing to participate in the study or not in a position to give consent.

Design outcomes

Primary

Measure	Time frame
changes observed after trial intervention in terms of Fasting and Postprandial blood Glucose; HbA1C% and Lipid Profile. Timepoint: at time registration - 0 month after 1st month after 2nd month after 3rd month	—

Secondary

Measure	Time frame
subjective parameters - Polyuria, polyphagia,etc. Lipid profile, Inflammatory markers - IL-6, 4, CRPTimepoint: At time of registration - 0 month after 1st month after 2nd month after 3rd month	—

Countries

India

Contacts

Public ContactDr Ajai Kumar Pandey

IIT, BHU

skmishra.phe@itbhu.ac.in9793523844

Outcome results